IDEAYA Biosciences(US:IDYA) Prnewswireยท2025-04-01 10:00Group 1 - IDEAYA Biosciences, Inc. is participating in two upcoming investor relations events, including the 2025 RBCCM Ophthalmology Conference and the Stifel 2025 Virtual Targeted Oncology Forum [1] - The company will have fireside chats featuring its President and CEO Yujiro S. Hata and Chief Medical Officer Darrin Beaupre, hosted by industry analysts [1] - A live audio webcast of these events will be available on the IDEAYA website, with a replay accessible for 30 days post-event [1] Group 2 - IDEAYA is focused on precision medicine in oncology, developing targeted therapeutics based on molecular diagnostics [2] - The company's strategy includes identifying and validating translational biomarkers to select patient populations that are most likely to benefit from its therapies [2] - IDEAYA is particularly engaged in synthetic lethality, which is an emerging area in precision medicine targeting [2]